Enbrel Uses
Links shared publicly online about this topic
Treating Psoriasis If Enbrel Fails
webmd.com — “If the drug Enbrel stops working, people with psoriasis have two effective options, new research suggests.” View full resource at webmd.com
Most Recently Shared on March 8, 2010 at 11:56 pm By:
When the drug Enbrel stops working, people with psoriasis have two effective options, new research suggests. http://bit.ly/bh6n8X
Comments of using Enbrel, Methotrexate (study 3186106) - eHealthMe.com
ehealthme.com — “i startted on Embrel Sept. 2011 it took approx 3 months before i saw any positive effects, ihave had chest inf. and 2 flare ups, what bothers me most is constant nausea and dry heaving and fatigue, the pain is managable now but my quality of life is not very good as i am too tired to do much of anything although this is preferable to the pain, i feel as if i am between a rock and a hard place!” View full resource at ehealthme.com
Most Recently Shared on December 26, 2011 at 4:46 pm By:
i startted on Embrel Sept. 2011 it took approx 3 months before i saw any positive effects, ihave had chest inf http://t.co/EPyfkzDd
FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009
drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009” View full resource at drugs.com
Most Recently Shared on August 31, 2009 at 8:40 pm By:
FDA Alert - Update: FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/SB68Y
FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)
drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)” View full resource at drugs.com
Most Recently Shared on August 5, 2009 at 1:04 am By:
FDA Alert - FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/xqXMR
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
fda.gov — “Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)” View full resource at fda.gov
Most Recently Shared on August 5, 2009 at 4:45 pm By:
FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV
MediGuard.org - Enbrel | Drug safety information | Monitoring more than 11,000 patients
mediguard.org — “MediGuard.org - Enbrel | Drug safety information | Monitoring more than 11,000 patients” View full resource at mediguard.org
Most Recently Shared on February 8, 2011 at 10:17 pm By:
MediGuard.org Health Organization
Approx 10% of #enbrel users experience injection site reactions: http://tinyurl.com/4ky9fnw
Comments of using Lisinopril And Hydrochlorothiazide, Levothyroxine Sodium, Omeprazole, Lipitor, Prednisone, Folic Acid, Methotrexate Sodium, Enbrel (study 4038712) - eHealthMe.com
ehealthme.com — “I have not had any successful results from either Enbrel and/or methotrexate. Doctor and I are considering other alternatives. Prednisone, in either pill or injection, has worked the best, but concerned about long-term use.” View full resource at ehealthme.com
Most Recently Shared on December 27, 2011 at 1:20 am By:
I have not had any successful results from either Enbrel and/or methotrexate. Doctor and I are considering ot http://t.co/JHzD9uRR
Medical News: ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk - in Meeting Coverage, ACR from MedPage Today
medpagetoday.com — “CHICAGO -- Long-term treatment with the biologic agent etanercept (Enbrel) is not only effective against rheumatoid arthritis, but reduces the patient's risk of heart attack and malignancy, and may al” View full resource at medpagetoday.com
Most Recently Shared on November 11, 2011 at 1:00 am By:
Urology & Nephrology OW Health
ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk (CME/CE): CHICAGO (MedPage Today) -- Long-term treatment ... http://t.co/YT180J1O
Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA - US News and World Report
health.usnews.com — “Agency strengthens 'black box' warning on medicines such as Enbrel, Remicade” View full resource at health.usnews.com
Most Recently Shared on August 5, 2009 at 3:30 pm By:
Hasbro Hosp/Nancy Children's Hospital and Hospital
FDA says Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk/warning on meds like Enbrel and Remicade. http://tinyurl.com/nm2uyv
Psoriasis medications' link to heart problems not clear: study - latimes.com
latimes.com — “Doctors should use caution prescribing newer psoriasis medications because the risk of heart-related side effects is unclear at this time, study finds.” View full resource at latimes.com
Most Recently Shared on August 23, 2011 at 10:42 pm By:
Psoriasis medications' link to heart problems not clear: study: Psoriasis medications, such as Enbrel and Remica... http://t.co/4BnwFZc
Protalix Reports Preclinical Data On Anti-TNF Follow-on Biologic Arthritis Drug
medicalnewstoday.com — “Protalix biotherapeutics, inc. (nyse-amex: plx), reported preclinical data on pr-antitnf, a biosimilar version of etanercept (enbrel™). produced using the company's proprietary procellex&tra” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2009 at 10:46 am By:
MNT Arthritis News Health News
Protalix Reports Preclinical Data On Anti-TNF Follow-on Biologic Arthritis Drug: Protalix Biotherapeutics, Inc. .. http://bit.ly/WdV9C
arthritis? - Lap Band Talk Forums
lapbandtalk.com — “Im going to my first meeting on the Lap Band and wonder if my psoriatic arthritis and Enbrel use will keep me from being able to get the Lap Band?? A...” View full resource at lapbandtalk.com
Most Recently Shared on June 13, 2011 at 8:35 pm By:
Alex Brecher Support and ePatient
Lap Band Talk - arthritis? http://bit.ly/iw81P4
New Patent Could Be Worth $6 A Share To Amgen - Yahoo! News
news.yahoo.com — “From Yahoo! News: Geoffrey Porges and his team of analysts at Sanford C. Bernstein took another look at the patent Amgen was issued last week on the top-selling drug Enbrel, used to treat rheumatoid arthritis, psoriasis, and other immune diseases. They found that the patent was more valuable than it initially appeared, because [...]” View full resource at news.yahoo.com
Most Recently Shared on November 28, 2011 at 2:58 pm By:
New Patent Could Be Worth $6 A Share To Amgen: Geoffrey Porges and his team of analysts at Sanford C. Bernstein ... http://t.co/JbWWuK5t
Natural Herbs Can Relieve Many Painful Disorders | ThirdAge Articles
thirdage.com — “Source FieldsArticle Source: YellowBrixArticle Source Extra Info: Tulsa World Suffering from knee pain? A free pain relief kit may help. Learn More Now!” View full resource at thirdage.com
Most Recently Shared on August 25, 2009 at 7:04 pm By:
Natural Herbs Can Relieve Pain http://bit.ly/3H9fBF
Medical News: Anti-TNF Drug Works in Ankylosing Spondylitis - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “Treatment with the tumor necrosis factor inhibitor etanercept (Enbrel) relieved the signs and symptoms of ankylosing spondylitis to a greater extent than the commonly used disease-modifying drug sulfa” View full resource at medpagetoday.com
Most Recently Shared on June 7, 2011 at 3:48 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday Anti-TNF Drug Works in Ankylosing Spondylitis (CME/CE) http://bit.ly/kEWDiG #medical #Health
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Healthy Society
Health news, If I'd known I was going to live so long, I'd have taken better care of myself. , don't make the same mistake.
-
eHealthMe.com
eHealthMe provides health professionals and patients personalized tools to study millions of drug reports from FDA and community in real time.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
